ReutersSanofi Joins Medtronic to Develop New Diabetes DevicesBusinessweekSanofi, the maker of the insulin product Lantus, and Medtronic Inc. (MDT:US), the world’s biggest maker of heart-rhythm devices, will work together to develop combinations of medicines and devices to battle diabetes, which kills a person every six seconds.Sanofi, Medtronic join on diabetes drugs, devicesFort Mills TimesNew rivals to top diabetes drug Lantus show promise in studiesReutersPatients Continuing On Sanofi’s Lantus® Had Lower Blood Sugar Levels Than …MarketWatchall 107 news articles …Read Full Story
Sanofi Joins Medtronic to Develop New Diabetes Devices - Businessweek
Real Estate of Cebu
